Hexiu Su
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Neuroblastoma Research and Treatments
Papers in
-
- Epigenetics and DNA Methylation 2
- Ubiquitin and proteasome pathways 2
- RNA modifications and cancer 2
-
- Neuroblastoma Research and Treatments 4
- Co-authors
- Hudan Liu (10 shared papers)Guoliang Qing (9 shared papers)Yufeng Hu (6 shared papers)Daibiao Xiao (2 shared papers)Ming Yue (3 shared papers)Jue Jiang (2 shared papers)Ping Ren (1 shared paper)Feng Li (1 shared paper)
- Journals
- Scientific Reports (2 papers)Molecular Cancer Therapeutics (1 paper)Blood (1 paper)Haematologica (1 paper)Carcinogenesis (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Hexiu Su
11 papers receiving 402 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 121
- Neurology 58
- Oncology 101
- Molecular Biology 275
- Cell Biology 63
Countries citing papers authored by Hexiu Su
This map shows the geographic impact of Hexiu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hexiu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hexiu Su more than expected).
Fields of papers citing papers by Hexiu Su
This network shows the impact of papers produced by Hexiu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hexiu Su. The network helps show where Hexiu Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Hexiu Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 130 | |
| 2 | 2020 | 86 | |
| 3 | 2015 | 69 | |
| 4 | 2016 | 30 | |
| 5 | 2014 | 28 | |
| 6 | 2018 | 26 | |
| 7 | 2020 | 23 | |
| 8 | 2020 | 9 | |
| 9 | 2017 | 3 | |
| 10 | 2014 | 1 | |
| 11 | 2018 | 1 |
About Hexiu Su
Hexiu Su is a scholar working on Molecular Biology, Neurology, Public Health, Environmental and Occupational Health, Surgery and Cell Biology, having authored 11 papers that have together received 406 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Neuroblastoma Research and Treatments (4 papers), Epigenetics and DNA Methylation (2 papers), Ubiquitin and proteasome pathways (2 papers), Microtubule and mitosis dynamics (2 papers), RNA modifications and cancer (2 papers), Acute Myeloid Leukemia Research (1 paper) and Genetics and Neurodevelopmental Disorders (1 paper). The work is most often cited by research in Cancer Research (121 citations), Neurology (58 citations), Oncology (101 citations), Molecular Biology (275 citations) and Cell Biology (63 citations). Hexiu Su has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Hudan Liu, Guoliang Qing, Yufeng Hu, Daibiao Xiao, Ming Yue, Jue Jiang, Ping Ren, Feng Li, Hai‐Ning Du and Ruijuan Xiu. Their work appears in journals such as Scientific Reports, Molecular Cancer Therapeutics, Blood, Haematologica and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.